Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

US Patent 6884806 · Granted Apr 26, 2005

Estimated economic value: $49,727,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Macrocycles as factor xia inhibitors2025
Macrocycles as factor XIA inhibitors2021
ROR γ modulators2021
Heterocyclic compounds useful as modulators of TNF alpha2020
Tricyclic sulfones as RORγ modulators2020
Supression of IgE production by compounds derived from traditional chinese medic2019
Macrocycles as factor XIa inhibitors2019
Cyclic compounds useful as modulators of TNF α2019
Tricyclic heterocyclic compounds useful as inhibitors of TNF2019
Tricyclic sulfones as RORγ modulators2019
Substituted tricyclic heterocyclic compounds2019
Tricyclic sulfones as RORγ modulators2017